Mr. Boyse was most recently Chief Operating Officer of Medicsight PLC, a subsidiary company of Medicsight, Inc. He joined Medicsight in May 2005, with 15 years experience in the software development sector, where he developed a broad range of experience in markets as diverse as automotive and telecommunications.
Tim Paterson-Brown, Medicexchange's Chairman, commented, "Adam's contribution to the product development, regulatory strategy and commercialization of our Medicsight PLC business has been significant. I am confident in his leadership of Medicexchange PLC, which we believe will fundamentally change the way the world wide clinical community gains access to market leading clinical software applications."
"I am impressed with Medicexchange's strategic vision and look forward to working with our business partners and affiliates for continued business growth," said Boyse.
Mr. Boyse will work from Medicexchange's new offices in Hammersmith, London.
About Medicsight, Inc.
Medicsight, Inc. is the parent company to both Medicexchange.com, an online multi-vendor sales channel for diagnostic, treatment and surgery planning solutions, and to Medicsight plc, a leading developer of computer- aided detection (CAD) technologies and software. Medicexchange.com, is an online multi-vendor sales channel for diagnostic, treatment and surgery planning solutions for cardiac, thoracic, orthopedic, women's and abdominal imaging. Medicexchange.com provides these solutions in a low-cost, on-demand and digitally-downloadable format for medical imaging professionals, providing access to information and products that they would traditionally have difficulty accessing. The CAD technology, which is developed by its subsidiary, Medicsight plc, is tested using one of the world's largest databases of verified CT scan data. Medicsight plc's software solutions help clinicians identify, measure, and analyze suspicious pathology, such as colorectal polyps and lung lesions. The company's CAD products include ColonCAD API, the first CAD technology available for CT colonography, and LungCAD API. Headquartered in London, Medicsight, Inc. employs more than 60 people and also has offices in the United States, Japan, and China. Product and company information can be found on http://www.medicsight.com. Stock symbol: MGT.
All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward- looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.
Company contacts: Medicexchange PLC 66 Hammersmith Road London W14 8UD United Kingdom info@medicexchange.com
For more information: Medicsight, Inc. David Mason, Executive Vice President, Corporate Development +1 615-665-9007
Investors Stephanie Carrington, +1 646-536-7017
Source: Medicexchange PLC
